Todd Dietrick, MD
Adult Reconstructive Orthopaedic Surgery · Pasadena, CANPI 1619963444
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $30,970 of the $47,225 with a category attached, or 65.6%. Ortho Development Corporation accounts for 88.5% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $36,444, 9.4 times the $3,889 reported in 2019.
Across 72 payments — averaging $655.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ortho Development Corporation$42K
- Medical Device Business Services, Inc.$3K
- Zimmer Biomet$2K
- Smith+Nephew$277
- Johnson & Johnson$167
- KCI USA, Inc.$13
- plus $13 from 1 others
What the payments were for
- Royalty or licence$30,97066%
- Consulting fees$12,41026%
- Travel & lodging$5681%
- Food & beverage$3,2777%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ortho Development Corporation | 33 | $41,782 |
| Medical Device Business Services, Inc. | 2 | $3,175 |
| Zimmer Biomet | 28 | $1,799 |
| Smith+Nephew | 3 | $277 |
| Johnson & Johnson | 4 | $167 |
| KCI USA, Inc. | 1 | $13 |
| Next Science LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Trivicta$38,613
- DHS$3,160
- ORTHOPEDIC CABLE / PERIPROSTHETIC SYSTEM$3,160
- TFN ADVANCED$3,160
- BKS TriMax$212
- Persona$172
- G7$159
- Persona Revision$145
- mymobility Platform$138
- Arcos$123
- Legend$121
- ROSA$120
- ROSA-Knee$118
- Legion$102
How this compares
$47,225 in reported general payments places this provider in the 70th percentile of 136 adult reconstructive orthopaedic surgery providers in California.
See all adult reconstructive orthopaedic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 263 | $8,833 |
| EliquisApixaban | 21 | $7,825 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 280 | $3,016 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 167 | $1,398 |
| Cefadroxil | 246 | $1,369 |
| Pantoprazole Sodium | 166 | $759 |
| Amoxicillin | 124 | $260 |
| Clindamycin Hcl | 33 | $192 |
| Gabapentin | 31 | $187 |
| Omeprazole | 38 | $163 |
| Cephalexin | 22 | $162 |
| Famotidine | 15 | $128 |
| Tramadol Hcl | 49 | $110 |
| Meloxicam | 29 | $68 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $41 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Pasadena
- William MaloneyStanford$11.1M
- James CaillouetteNewport Beach$4.8M
- William LongLos Angeles$2.8M
- John DearbornMenlo Park$2.5M
- William Bugbeela Jolla$2.1M
- James HuddlestonStanford$1.5M
- Alexander SahFremont$1.2M
- John DianaNapa$981K
- Thomas DonaldsonColton$893K
- Derek AmanatullahStanford$828K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.